Logo image of UPC

UNIVERSE PHARMACEUTICALS INC (UPC) Stock Analyst Earnings Estimates

NASDAQ:UPC - Nasdaq - KYG9442G1203 - Common Stock - Currency: USD

0.1984  +0.06 (+39.23%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
UPC revenue by date.UPC revenue by date.
47.98M
56.29%
40.14M
-16.34%
32.309M
-19.51%
EBITDA
YoY % growth
UPC ebitda by date.UPC ebitda by date.
14.04M
31.71%
-6.91M
-149.22%
-3.018M
56.32%
EBIT
YoY % growth
UPC ebit by date.UPC ebit by date.
13.59M
32.59%
-7.44M
-154.75%
-3.527M
52.60%
Operating Margin
UPC operating margin by date.UPC operating margin by date.
28.32%-18.54%-10.92%
EPS
YoY % growth
UPC eps by date.UPC eps by date.
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
UPC Yearly EPS VS EstimatesUPC Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
12.884M
-30.23%
%
Q4 2023
Q2Q % growth
13.842M
-13.16%
%
Q2 2023
Q2Q % growth
18.467M
-23.69%
%
Q4 2022
Q2Q % growth
15.94M
-66.78%
%
Q2 2022
Q2Q % growth
24.2M
-0.38%
%
Q4 2021
Q2Q % growth
47.98M
56.29%
%
Q2 2021
Q2Q % growth
24.293M
48.22%
%
Q4 2020
Q2Q % growth
30.7M
-7.61%
%
Q2 2020
Q2Q % growth
16.39M
-9.60%
%
UPC Yearly Revenue VS EstimatesUPC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A